IRELAnD: Investigating the Role of Early Low-dose Aspirin in Diabetes
Status:
Unknown status
Trial end date:
2021-09-01
Target enrollment:
Participant gender:
Summary
To investigate the effect of aspirin therapy initiated in the first trimester of pregnancy in
women with pregestational type I or type II diabetes on a composite clinical measure of
placental dysfunction (preeclampsia, preterm birth less than 34 weeks, birthweight below the
10th centile or perinatal mortality).